Reviva Pharmaceuticals Holdings Inc a prominent latestage pharmaceutical company specializing in addressing unmet medical needs in central nervous system inflammatory

Imugene Limited has initiated enrollment for its expansion study targeting bile tract cancer patients This comes after completing the fifth cohort in the high dose segment of the intratumoural

BC Platforms and NTT Life Science Corporation have teamed up in an exclusive partnership to advance datadriven medicine particularly in Japan The collaboration

Teva Pharmaceuticals a subsidiary of Teva Pharmaceutical Industries Ltd has released findings from a Phase trial examining the effectiveness and safety of AJOVY in preventing migraines in adult Chinese

SenJam Pharmaceutical an innovative player in the life sciences field is embarking on its third strategic collaboration this time with KVKTech a leading Specialty Pharmaceutical Manufacturing company

Mabwell an innovative biopharmaceutical company with a complete industry chain has announced that its whollyowned subsidiary Tmab has received marketing authorization approval from the National Medical

When developing new drugs nutritional products or pesticides its critical that unknown molecules are identified correctly But accurate identification is a lengthy process and all too often unsuccessful

Actinogen Medical Limited announces that the first patient has been randomized and treated in the XanaMIA phase b clinical trial in patients with biomarkerpositive mild to moderate Alzheimers disease This represents the culmination of the site and screening setup phase of the trial when patient

CorMedix Inc a biopharmaceutical company focused on developing and commercializing therapeutic products for lifethreatening diseases and conditions today announced DefenCath

Neumora Therapeutics Inc a clinicalstage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical and preclinical brain disease programs today announced that the Phase trial of NMRA has been placed on clinical hold by the US Food and Drug Administration

Nxera Pharma Co Ltd formerly known as Sosei Group or Sosei Heptares today announces that its operating business Nxera Pharma Korea has entered into an exclusive supply

Dot Compliance a provider of AIenabled Quality Management System solutions today announced it has raised million in Series B extension funding marking a significant upround